Issue 12, 2022

Nanoparticle-based non-viral CRISPR delivery for enhanced immunotherapy

Abstract

The CRISPR Cas9 system has received considerable attention due to its simplicity, efficiency, and high precision for gene editing. The development of various therapeutic applications of the CRISPR system is under active research. In particular, its proven effects and promise in immunotherapy are of note. CRISPR/Cas9 components can be transported in various forms, such as plasmid DNA, mRNA of the Cas9 protein with gRNA, or a ribonucleoprotein complex. Even with its proven gene editing superiority, there are limitations in delivering the CRISPR system to target cells. CRISPR systems can be delivered via physical methods, viral vectors, or non-viral carriers. The development of diverse types of nanoparticles that could be used as non-viral carriers could overcome the disadvantages of physical techniques and viral vectors such as low cell viability, induction of immune response, limited loading capacity, and lack of targeting ability. Herein, we review the recent developments in applications of CRISPR system-mediated non-viral carriers in immunotherapy, depending on the targeting cell types, and discuss future research directions.

Graphical abstract: Nanoparticle-based non-viral CRISPR delivery for enhanced immunotherapy

Article information

Article type
Feature Article
Submitted
25 অক্টো 2021
Accepted
07 জানু 2022
First published
07 জানু 2022

Chem. Commun., 2022,58, 1860-1870

Nanoparticle-based non-viral CRISPR delivery for enhanced immunotherapy

H. Shin and J. Kim, Chem. Commun., 2022, 58, 1860 DOI: 10.1039/D1CC05999H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements